B · Normal
On October 22, Eli Lilly and Company held a groundbreaking ceremony in Richmond to expand U.S. manufacturing capabilities for next-generation anti-cancer drugs and advance its plan to build 10 new production bases in the United States since 2020.
Global market intelligence 🕐 2026-10-22 22:32

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet